Maher Abdul‐Hay

3.7k total citations · 2 hit papers
42 papers, 2.3k citations indexed

About

Maher Abdul‐Hay is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Maher Abdul‐Hay has authored 42 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 20 papers in Oncology and 13 papers in Immunology. Recurrent topics in Maher Abdul‐Hay's work include Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and CAR-T cell therapy research (8 papers). Maher Abdul‐Hay is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and CAR-T cell therapy research (8 papers). Maher Abdul‐Hay collaborates with scholars based in United States, France and Italy. Maher Abdul‐Hay's co-authors include Ivan de Kouchkovsky, Leonard Naymagon, Helen Ma, Youmna Kfoury, Olivier Hermine, Hugues de Thé, Claudine Pique, Renaud Mahieux, Ali Bazarbachi and Rihab Nasr and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Maher Abdul‐Hay

37 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

‘Acute myeloid leukemia: a comprehensive review and 2016 update’

2016 928 citations Ivan de Kouchkovsky, Maher Abdul‐Hay Blood Cancer Journal profile →
Acute lymphoblastic leukemia: a comprehensive review and 2017 update

2017 802 citations Maher Abdul‐Hay et al. Blood Cancer Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maher Abdul‐Hay United States	13	1.0k	1.0k	568	564	396	42	2.3k
Kajsa Paulsson Sweden	33	1.1k 1.1×	1.0k 1.0×	1.2k 2.1×	409 0.7×	482 1.2×	88	2.8k
Leonid Karawajew Germany	30	828 0.8×	1.1k 1.1×	882 1.6×	573 1.0×	499 1.3×	82	2.4k
Ronald W. Stam Netherlands	26	1.2k 1.2×	1.6k 1.5×	1.2k 2.1×	502 0.9×	154 0.4×	75	2.7k
Francis Lacombe France	28	952 0.9×	948 0.9×	393 0.7×	448 0.8×	418 1.1×	82	2.4k
N Feller Netherlands	21	1.1k 1.0×	975 1.0×	302 0.5×	1.2k 2.2×	413 1.0×	56	2.5k
Dianna S. Howard United States	17	900 0.9×	1.2k 1.2×	191 0.3×	652 1.2×	282 0.7×	66	2.3k
Utz Krug Germany	25	980 0.9×	1.1k 1.1×	269 0.5×	432 0.8×	233 0.6×	82	2.0k
David P. Curley United States	18	1.0k 1.0×	2.2k 2.1×	169 0.3×	954 1.7×	560 1.4×	24	3.5k
Sixuan Qian China	25	496 0.5×	754 0.7×	119 0.2×	321 0.6×	893 2.3×	154	2.1k
Todd Busman United States	20	459 0.4×	1.5k 1.4×	238 0.4×	655 1.2×	415 1.0×	42	2.6k

Countries citing papers authored by Maher Abdul‐Hay

Since Specialization

Citations

This map shows the geographic impact of Maher Abdul‐Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher Abdul‐Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher Abdul‐Hay more than expected).

Fields of papers citing papers by Maher Abdul‐Hay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maher Abdul‐Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher Abdul‐Hay. The network helps show where Maher Abdul‐Hay may publish in the future.

Co-authorship network of co-authors of Maher Abdul‐Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Maher Abdul‐Hay. A scholar is included among the top collaborators of Maher Abdul‐Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maher Abdul‐Hay. Maher Abdul‐Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malki, Monzr M. Al, Elizabeth Rich, Jason E. Hill, et al.. (2025). Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study. Leukemia Research. 152. 107690–107690. 2 indexed citations

Abdul‐Hay, Maher, et al.. (2025). TCL-1031: Allogeneic Hematopoietic Cell Transplant in T-Cell Lymphoma in the Era of Post-Transplant Cyclophosphamide-Based Graft-vs-Host Disease Prophylaxis Regimens: A Single-Center Retrospective Analysis. Clinical Lymphoma Myeloma & Leukemia. 25. S878–S878.

Abdul‐Hay, Maher, Onyee Chan, Namrata S. Chandhok, et al.. (2025). Preliminary anti-leukemia activity from A phase 1 study of cln-049, a novel anti-FLT3 x anti-CD3 bispecific T-cell engager, in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS). Blood. 146(Supplement 1). 768–768.

Narayan, Rupa, Ana Alfonso Piérola, William B. Donnellan, et al.. (2024). First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and Translational Science. 17(3). e13742–e13742. 14 indexed citations

Abdul‐Hay, Maher, et al.. (2024). Leukemia Cutis in Relapsed Acute Myeloid Leukemia: A Call for Distinct Classification. American Journal of Case Reports. 25. e943577–e943577.

Abdul‐Hay, Maher, et al.. (2024). Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia. Biomedicines. 12(8). 1768–1768. 3 indexed citations

Ohanian, Maro, Maher Abdul‐Hay, Tara L. Lin, et al.. (2024). Interim safety and efficacy of BP1001 in a phase II acute myeloid leukemia (AML) study.. Journal of Clinical Oncology. 42(16_suppl). 6511–6511. 1 indexed citations

Lurain, Kathryn, Ramya Ramaswami, Irene Ekwede, et al.. (2023). 1979P phase I trial of pembrolizumab in HIV-associated Kaposi sarcoma (KS). Annals of Oncology. 34. S1056–S1056. 2 indexed citations

Al‐Homsi, A. Samer, Sharon L. Gardner, Jingmei Hsu, et al.. (2023). PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation. Blood Advances. 7(14). 3604–3611. 17 indexed citations

10.

Modrek, Aram S., David J. Byun, Naamit K. Gerber, et al.. (2022). Pulmonary Toxic Effects After Myeloablative Conditioning With Total Body Irradiation Delivered via Volumetric Modulated Arc Therapy With Fludarabine. Practical Radiation Oncology. 12(6). e476–e480. 1 indexed citations

11.

Stock, Wendy, Jae H. Park, Ashkan Emadi, et al.. (2021). Safety and Pharmacokinetics of Calaspargase Pegol in Adults with Newly Diagnosed Philadelphia-Negative ALL: A Phase 2/3 Study. Blood. 138(Supplement 1). 4406–4406. 1 indexed citations

12.

Abdul‐Hay, Maher, et al.. (2020). Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant. SHILAP Revista de lepidopterología. 2(2). 49–49. 10 indexed citations

13.

Tegla, Cosmin, et al.. (2020). Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults. SHILAP Revista de lepidopterología. 2(1). 5–5. 19 indexed citations

14.

Williams, Louis, et al.. (2020). Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation. Frontiers in Immunology. 11. 636–636. 22 indexed citations

15.

Naymagon, Leonard & Maher Abdul‐Hay. (2019). Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature. Journal of Medical Case Reports. 13(1). 153–153. 6 indexed citations

16.

Azzi, Jacques, et al.. (2019). Human Herpes Virus-6 Encephalitis Following Autologous Blood and Marrow Transplant. SHILAP Revista de lepidopterología. 2(1). 32–32. 1 indexed citations

17.

Abdul‐Hay, Maher, et al.. (2017). Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer Journal. 7(6). e577–e577. 802 indexed citations breakdown →

18.

Naymagon, Leonard & Maher Abdul‐Hay. (2016). Novel agents in the treatment of multiple myeloma: a review about the future. Journal of Hematology & Oncology. 9(1). 52–52. 144 indexed citations

19.

Kouchkovsky, Ivan de & Maher Abdul‐Hay. (2016). ‘Acute myeloid leukemia: a comprehensive review and 2016 update’. Blood Cancer Journal. 6(7). e441–e441. 928 indexed citations breakdown →

20.

Desai, Anjali, et al.. (2014). Novel Agents in the Treatment of Chronic Lymphocytic Leukemia: A Review About the Future. Clinical Lymphoma Myeloma & Leukemia. 15(6). 314–322. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact